Celldex Therapeutics, Inc. · NASDAQ:CLDX

FMR LLC reported a 7.30% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 12, 2025

FMR LLC reported a 7.30% stake in Celldex Therapeutics, Inc., 4,857,668 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).

Stake
7.30%
Shares
4,857,668
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC7.30%4,857,668
Abigail P. Johnson7.30%4,857,668

Source

View original at SEC

Related